Company & Activity
● Production of pharmaceutical cannabis / medical companies as main buyer
● Investments already made : around CHF 7,000,000
● An experienced team, previous success in agriculture and cannabinoids
● Our client covers the entire value chain, has a project to produce and supply unique cannabis-based medicines to improve public health. Directly from the seed to the patient

● Production insured from the start of production. High-tech indoor cultivation process
● Natural and very high quality production. Consistent quality. 100% Swiss culture
● Income of CHF 11,700,000. - / from 2022 secured thanks to a contract for the purchase of production by a Swiss company

● Objective of the fundraising: start production, refinance an existing loan, direct sales to the medical sector.
● Amount to raise: CHF 8'000'000.
● A minimum annual return of 10% or distributed dividend with 25% premium on Class A dividends. Type of share: preferred shares (preferred dividends).
● Targeted geographic sector: Switzerland, Germany, France, Italy, then Europe and globally within 4 years